The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Bach, Stephan
Funded by
US Dept of Agriculture
Complete concentration analysis of eprinomectin in serum obtained from blood samples collected at the USDA, ARS, Cattle Fever Tick Research Laboratory (CFTRL) in collaboration with the ARS scientists in support of the continuation of research studying the interaction between Bm86 vaccine and a long-acting eprinomectin injectable formulation. Blood samples collected during the study will be processed at the USDA, ARS, CFTRL to obtain serum. ARS will provide the serum samples to the University of Texas at San Antonio (UTSA) to conduct the analysis per the one year field study.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
and HSIL. Secondly
Collaborating Institutions
we intend to compare the clinical performance of the Molecular Pap to current cervical cancer screening (traditional Pap +/- cobas® hrHPV) in a head-to-head challenge to continue the development of this molecular diagnostic.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
low-grade squamous intraepithelial lesion (LSIL)
Funded by
affordable
Collaborating Institutions
and high-grade squamous intraepithelial lesion (HSIL). This Molecular Pap may circumvent the resource and expertise challenges of cytology-based screening programs. Such an automated
computerized test possesses tremendous practical value in several respects: 1) increased throughput and accuracy
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Lee, Soo Chan
Funded by
Univ of TX HSC at San Antonio 745
Growing evidence suggest that increased gut permeability and bacterial dysbiosis contribute to several human diseases including inflammatory bowel diseases (IBDs). Therefore. it has been suggested that reconstruction or modulation of the intestinal bacterial microbiome represents a novel and well-perceived treatment option. Previous studies have been largely focused on bacteria. although accumulating evidence indicates that intestinal fungi are also associated with inflammation in the gut. However.
